Technical Specifications

• CAS Number: 910463-68-2
  
• Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
  
• Molecular Weight: 4113.6 g/mol
  
• PubChem ID: 56843331
  
• Purity: ≥99% (HPLC tested)
  
• Form: Lyophilized powder
• Synthesis Method: Solid-phase peptide synthesis
  

Analytical & Testing

Each batch of Semaglutide (Sema) undergoes high-performance liquid chromatography (HPLC) and mass spectrometry (MS) analysis to verify purity, identity, and analytical consistency. A corresponding Certificate of Analysis (COA) is available for each batch.

Handling & Storage

This compound should be handled by qualified professionals in controlled laboratory environments. Proper storage conditions should be maintained to preserve compound stability and structural integrity.

Research Context

In preclinical and laboratory research models, Semaglutide has been examined across metabolic, endocrine, and cardiovascular research systems. Research focus includes:

• GLP-1 receptor signaling pathways
• Incretin-related activity models
• Hormonal pathway interactions
• Cellular signaling mechanisms

These observations are limited to controlled experimental environments and support ongoing laboratory investigations.

Research Application Scope

Semaglutide (Sema) continues to be evaluated for its relevance in experimental biology, particularly within studies involving incretin signaling, receptor-level interactions, and biochemical pathway analysis.

Use Statement

For laboratory research use only. Intended strictly for in vitro research applications.

Disclaimer

All products currently listed on this site are for research purposes ONLY.